vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and Upstart Holdings, Inc. (UPST). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $296.1M, roughly 1.7× Upstart Holdings, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 6.3%, a 0.5% gap on every dollar of revenue. On growth, Upstart Holdings, Inc. posted the faster year-over-year revenue change (35.2% vs -1.7%). Over the past eight quarters, Upstart Holdings, Inc.'s revenue compounded faster (52.2% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Upstart is an AI lending platform that partners with banks and credit unions to provide consumer loans using non-traditional variables, such as education and employment, to predict creditworthiness.
MD vs UPST — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $296.1M |
| Net Profit | $33.7M | $18.6M |
| Gross Margin | — | — |
| Operating Margin | 9.9% | 6.4% |
| Net Margin | 6.8% | 6.3% |
| Revenue YoY | -1.7% | 35.2% |
| Net Profit YoY | 10.5% | 776.4% |
| EPS (diluted) | $0.40 | $0.20 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $296.1M | ||
| Q3 25 | $492.9M | $277.1M | ||
| Q2 25 | $468.8M | $257.3M | ||
| Q1 25 | $458.4M | $213.4M | ||
| Q4 24 | $502.4M | $219.0M | ||
| Q3 24 | $511.2M | $162.1M | ||
| Q2 24 | $504.3M | $127.6M | ||
| Q1 24 | $495.1M | $127.8M |
| Q4 25 | $33.7M | $18.6M | ||
| Q3 25 | $71.7M | $31.8M | ||
| Q2 25 | $39.3M | $5.6M | ||
| Q1 25 | $20.7M | $-2.4M | ||
| Q4 24 | $30.5M | $-2.8M | ||
| Q3 24 | $19.4M | $-6.8M | ||
| Q2 24 | $-153.0M | $-54.5M | ||
| Q1 24 | $4.0M | $-64.6M |
| Q4 25 | 9.9% | 6.4% | ||
| Q3 25 | 13.8% | 8.5% | ||
| Q2 25 | 12.8% | 1.8% | ||
| Q1 25 | 7.0% | -2.1% | ||
| Q4 24 | 7.8% | -2.2% | ||
| Q3 24 | 6.6% | -27.8% | ||
| Q2 24 | -31.3% | -43.5% | ||
| Q1 24 | 3.2% | -52.8% |
| Q4 25 | 6.8% | 6.3% | ||
| Q3 25 | 14.5% | 11.5% | ||
| Q2 25 | 8.4% | 2.2% | ||
| Q1 25 | 4.5% | -1.1% | ||
| Q4 24 | 6.1% | -1.3% | ||
| Q3 24 | 3.8% | -4.2% | ||
| Q2 24 | -30.3% | -42.7% | ||
| Q1 24 | 0.8% | -50.5% |
| Q4 25 | $0.40 | $0.20 | ||
| Q3 25 | $0.84 | $0.23 | ||
| Q2 25 | $0.46 | $0.05 | ||
| Q1 25 | $0.24 | $-0.03 | ||
| Q4 24 | $0.37 | $-0.01 | ||
| Q3 24 | $0.23 | $-0.07 | ||
| Q2 24 | $-1.84 | $-0.62 | ||
| Q1 24 | $0.05 | $-0.74 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $652.4M |
| Total DebtLower is stronger | $570.5M | — |
| Stockholders' EquityBook value | $865.9M | $798.8M |
| Total Assets | $2.2B | $3.0B |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $652.4M | ||
| Q3 25 | $340.1M | $489.8M | ||
| Q2 25 | $224.7M | $395.9M | ||
| Q1 25 | $99.0M | $599.8M | ||
| Q4 24 | $229.9M | $788.4M | ||
| Q3 24 | $103.8M | — | ||
| Q2 24 | $19.4M | — | ||
| Q1 24 | $8.0M | — |
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $865.9M | $798.8M | ||
| Q3 25 | $890.7M | $743.7M | ||
| Q2 25 | $833.8M | $722.0M | ||
| Q1 25 | $789.2M | $676.6M | ||
| Q4 24 | $764.9M | $633.2M | ||
| Q3 24 | $732.5M | $595.5M | ||
| Q2 24 | $706.5M | $594.7M | ||
| Q1 24 | $856.2M | $612.8M |
| Q4 25 | $2.2B | $3.0B | ||
| Q3 25 | $2.2B | $2.9B | ||
| Q2 25 | $2.1B | $2.5B | ||
| Q1 25 | $2.0B | $2.3B | ||
| Q4 24 | $2.2B | $2.4B | ||
| Q3 24 | $2.1B | $1.8B | ||
| Q2 24 | $2.0B | $1.8B | ||
| Q1 24 | $2.2B | $1.9B |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $108.6M |
| Free Cash FlowOCF − Capex | — | $108.4M |
| FCF MarginFCF / Revenue | — | 36.6% |
| Capex IntensityCapex / Revenue | — | 0.1% |
| Cash ConversionOCF / Net Profit | 3.39× | 5.82× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $108.6M | ||
| Q3 25 | $137.3M | $-122.6M | ||
| Q2 25 | $137.2M | $-120.2M | ||
| Q1 25 | $-117.5M | $-13.5M | ||
| Q4 24 | $133.0M | $-110.9M | ||
| Q3 24 | $91.8M | $179.3M | ||
| Q2 24 | $107.0M | $65.3M | ||
| Q1 24 | $-125.2M | $52.6M |
| Q4 25 | — | $108.4M | ||
| Q3 25 | — | $-122.7M | ||
| Q2 25 | — | $-120.3M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $179.2M | ||
| Q2 24 | — | $65.3M | ||
| Q1 24 | — | $51.9M |
| Q4 25 | — | 36.6% | ||
| Q3 25 | — | -44.3% | ||
| Q2 25 | — | -46.7% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 110.5% | ||
| Q2 24 | — | 51.1% | ||
| Q1 24 | — | 40.6% |
| Q4 25 | — | 0.1% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.5% |
| Q4 25 | 3.39× | 5.82× | ||
| Q3 25 | 1.91× | -3.86× | ||
| Q2 25 | 3.49× | -21.43× | ||
| Q1 25 | -5.66× | — | ||
| Q4 24 | 4.36× | — | ||
| Q3 24 | 4.72× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -31.03× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
UPST
| Personal Lending Segment | $201.4M | 68% |
| Servicing Fees Net | $39.5M | 13% |
| Servicing Fees | $27.5M | 9% |
| Other | $15.7M | 5% |
| Borrower Fees | $8.4M | 3% |
| Collection Agency Fees | $3.5M | 1% |
